Opinion

Video

Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer (MIBC)

A panel of experts on bladder cancer introduce themselves and give an overview of the neoadjuvant therapy landscape for patients with muscle-invasive bladder cancer.

Related Videos
Rohan Garje, MD
Manmeet Ahluwalia, MD, MBA, FASCO
Mazyar Shadman, MD, MPH
Petros Grivas, MD, PhD; and Chandler Park, MD, MSc, FACP
Viktor Grünwald, MD, PhD
David A. Braun, MD, PhD, assistant professor, medicine (medical oncology), Louis Goodman and Alfred Gilman Yale Scholar, member, Center of Molecular and Cellular Oncology, Yale Cancer Center
Video 14 - "Key Takeaways in HER2-Mutated NSCLC"
Video 13 - "Treatment Considerations in HER2-Mutated NSCLC"
Sumanta Kumar Pal, MD, FASCO,
A panel of 5 experts on lung cancer